8,750
Total Claims
$2.0M
Drug Cost
1,308
Beneficiaries
$1,521
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
0%
Cost per patient vs peers
$1,521 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 7,037 claims · $164K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 669 | $755K |
| Rivaroxaban | 191 | $226K |
| Semaglutide | 99 | $144K |
| Empagliflozin | 113 | $135K |
| Sacubitril/Valsartan | 84 | $128K |
| Evolocumab | 140 | $121K |
| Dapagliflozin Propanediol | 103 | $117K |
| Dulaglutide | 36 | $51K |
| Alirocumab | 43 | $42K |
| Dronedarone Hcl | 22 | $32K |
| Rosuvastatin Calcium | 848 | $18K |
| Ivabradine Hcl | 20 | $17K |
| Semaglutide | 16 | $17K |
| Ezetimibe | 393 | $16K |
| Atorvastatin Calcium | 692 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About